Usana Health Sciences Inc (USNA)
EBITDA Growth
-133.93%
Quarterly · Period ending:
USNA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-133.93%period ending
Latest reported-133.93%period ending
USNA Quarterly EBITDA YoY % (238.89% → -133.93%)
Year-over-year change
High-resolution chart · PNG
USNA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -133.9261% | |
| -6.9392% | |
| -11.2882% | |
| -52.8824% | |
| 10.4947% | |
| -15.0464% | |
| -48.0128% | |
| -5.8952% | |
| -18.8723% | |
| -4.4703% | |
| 12.6077% | |
| -10.2786% | |
| -7.347% | |
| -13.2794% | |
| -24.7528% | |
| -37.4487% | |
| -42.3369% | |
| -21.886% | |
| -36.6729% | |
| -10.524% | |
| 32.3813% | |
| 10.9007% | |
| 14.3378% | |
| 24.6564% | |
| 22.5941% | |
| 9.8794% | |
| -2.1414% | |
| -17.0571% | |
| -33.27% | |
| -14.1985% | |
| 22.6787% | |
| 39.6613% | |
| 51.2142% | |
| 31.1033% | |
| 21.3377% | |
| -9.0261% | |
| -10.1148% | |
| 8.5035% | |
| -6.4577% | |
| -3.966% | |
| -0.9326% | |
| 12.4824% | |
| 8.8255% | |
| 28.8215% | |
| 31.2684% | |
| 8.9745% | |
| 11.4985% | |
| 0.315% | |
| -19.1565% | |
| -5.2221% | |
| 2.6301% | |
| 30.514% | |
| 53.8587% | |
| 38.237% | |
| 36.8423% | |
| 14.5493% | |
| 8.102% | |
| 7.1495% | |
| 6.8798% | |
| -0.5863% | |
| 27.1436% | |
| 16.9018% | |
| 20.6774% | |
| 52.4582% | |
| 19.492% | |
| 35.8705% | |
| 88.7074% | |
| 8.7659% | |
| -4.0957% | |
| 2.5174% | |
| -51.1043% | |
| -26.2049% | |
| -13.1513% | |
| -38.3596% | |
| 3.4494% | |
| -0.6496% | |
| 7.2445% | |
| 33.5307% | |
| 6.1768% | |
| 19.0447% | |
| 16.2463% | |
| 7.0523% | |
| 24.7008% | |
| 20.3707% | |
| 31.3034% | |
| 46.4652% | |
| 25.1746% | |
| 42.7396% | |
| 57.5095% | |
| 64.2439% | |
| 93.8012% | |
| 138.302% | |
| 163.7204% | |
| 192.7348% | |
| 172.6566% | |
| 222.1119% | |
| 48.1644% | |
| 51.7323% | |
| 15.4148% | |
| -13.302% |